Search company, investor...

Meidixi Bio



Total Raised


Date of IPO


About Meidixi Bio

Provider of one-stop pharmaceutical research and development (R&D) services. The company provides services in biotechnology research and advancing the process of new drug development. Service now spans cross medicinal chemistry, process chemistry, in vitro and in vivo DMPK, preclinical development and bioanalytical support.

Headquarters Location

Lane 67 Libing Road Building 5

Shanghai, Shanghai, 201299,


86 21-58591500

Missing: Meidixi Bio's Product Demo & Case Studies

Promote your product offering to tech buyers.

Reach 1000s of buyers who use CB Insights to identify vendors, demo products, and make purchasing decisions.

Missing: Meidixi Bio's Product & Differentiators

Don’t let your products get skipped. Buyers use our vendor rankings to shortlist companies and drive requests for proposals (RFPs).

Expert Collections containing Meidixi Bio

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

Meidixi Bio is included in 1 Expert Collection, including Biopharma Tech.


Biopharma Tech

5,241 items

Companies involved in the research, development, and commercialization of chemically- or biologically-derived therapeutic & theranostic drugs. Excludes vitamins/supplements, CROs/clinical trial services.

Latest Meidixi Bio News

cardiac safety services Market to Exhibit 15.4% CAGR; Global Trends, Size, Share, Regional Analysis by Key Players and Industry Forecast till 2029

Nov 22, 2022

Search jobs 22-Nov-2022 cardiac safety services Market to Exhibit 15.4% CAGR; Global Trends, Size, Share, Regional Analysis by Key Players and Industry Forecast till 2029 The global Cardiac Safety Services market is anticipated to witness high growth during the forecast period 2022-2029 The  Cardiac Safety Services Market  Research 2022-2029 report highlights market dynamics, ultra-modern trends, demand and upcoming tendencies impacting the general increase of the industry over the next numerous years. Cardiac Safety Services Market Report consists of an in depth evaluation of industry size, share, increase, and income in phrases of fee and volume, vital opportunities, and demanding situations of major key players. The file features funding feasibility, deliver-demand scenario, import-export status, home increase outlook, CAGR status, and forces analysis. This file contains a complete analysis of latest technologies, It is expert and special file that concentrates on key players, important collaborations, mergers, and accessions in conjunction with trending inventions and business rules which can be reviewed on this Cardiac Safety Services Market file. Furthermore, the file affords special analysis of costs, deliver chain, technological innovation and advances so as to similarly optimize product performance. The Cardiac Safety Services market file gives a complete study across all segments and shares information at the leading regions in the market. In addition, we also have our internal data forecasting model to forecast the growth of the market as much as 2029. Global cardiac safety services market is supportive and aims to reduce the progression of the disease. Data Bridge Market Research analyses that global cardiac safety services market will grow at a CAGR of 15.4% during the forecast period of 2022 to 2029. Get Sample PDF of Report at: Global Cardiac Safety Services Market Report Segments This report forecasts revenue growth in the country position and provides an analysis of the latest industry trends in each of the segments from 2022 to 2029. By Services (ECG/Holter Measurements, Blood Pressure Measurements, In Vitro Cardiac Safety Assessment Services, Cardiovascular Imaging, Real-Time Telemetry Monitoring, Central Over-Read of ECGS, Non-Invasive Cardiac Imaging, Physiologic Stress Testing, Thorough QT Studies, TQT and Exposure Response Modeling, Platelet Aggregation and Other Services), Phase (Phase 1, Phase 2 and Phase 3), Type End User Cardiac Safety Services Market Competitor Overview Koninklijke Philips N.V., Laboratory Corporation of America Holdings, IQVIA, Medpace, Ncardia, Certara, Eurofins Scientific, SGS SA, Banook, Celerion, Biotrial, NEXEL Co., Ltd, Richmond Pharmacology, PhysioStim, Shanghai Medicilon Inc Regional Industry Analysis Cardiac Safety Services Market North America Reasons to buy the Cardiac Safety Services Market Report The report includes a wealth of information such as the dash of market dynamics and opportunities during the forecast period The segments and sub-segments include quantitative, qualitative, value (millions of USD) and volume (units per million) data. Regional, sub-regional and national data include the forces of supply and demand along with their influence on the market. The competitive landscape comprises a part of the key players, new developments and strategies in the coming times. Comprehensive companies that offer products, relevant financial information, recent developments, geek analysis and strategies of these players. Summary of The Cardiac Safety Services Market Report: Cardiac Safety Services market competitive landscape provides details and information on manufacturer data. The report provides comprehensive analysis and accurate statistics on production capacity, prices and revenue per player for the period 2022-2029. As well as a detailed analysis supported by reliable statistics on the production, income (global and regional) of the players. THANKS FOR READING THIS ARTICLE. THE FINAL REPORT WILL ADD AN ANALYSIS OF THE IMPACT OF COVID19 ON THIS INDUSTRY. Browse Related Reports: Wearable Devices in Sports Market: About Data Bridge Market Research: An absolute way to forecast what future holds is to comprehend the trend today! Data Bridge Market Research set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge endeavours to provide appropriate solutions to the complex business challenges and initiates an effortless decision-making process. Data Bridge is an aftermath of sheer wisdom and experience which was formulated and framed in the year 2015 in Pune. Data Bridge Market Research has over 500 analysts working in different industries. We have catered more than 40% of the fortune 500 companies globally and have a network of more than 5000+ clientele around the globe. Data Bridge adepts in creating satisfied clients who reckon upon our services and rely on our hard work with certitude. We are content with our glorious 99.9 % client satisfying rate. If You Have Any Questions About This Report or Want More Information, Please Contact Us: Contact Us:

Meidixi Bio Frequently Asked Questions (FAQ)

  • Where is Meidixi Bio's headquarters?

    Meidixi Bio's headquarters is located at Lane 67 Libing Road, Shanghai.

  • What is Meidixi Bio's latest funding round?

    Meidixi Bio's latest funding round is IPO.

  • How much did Meidixi Bio raise?

    Meidixi Bio raised a total of $140.02M.

  • Who are the investors of Meidixi Bio?

    Investors of Meidixi Bio include Sinvo Group, Fortune Haven Capital, Xinze Venture Capital, Orient Securities Capital Investment and Renhe Capital.

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.